Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Episodic Migraine Clinical Trials

10 recruiting trials for Episodic Migraine. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
10
Total Trials
10
Recruiting Now
1
Phase 3 Trials
8
Sponsors

Recruiting Trials

RECRUITINGNCT07103694

i-NEED: NEw migrainE Drugs Database

Approved by the Food and Drug Administration (FDA) and the European Medicine Agency (EMA) starting in 2018, anti-CGRP monoclonal antibodies (anti-CGRP mAbs) represent the first...

Sponsor: IRCCS San Raffaele RomaEnrolling: 26411 location
RECRUITINGNCT06562413

Searching for Novel Biological Phenotypes in Migraine Patients Resistant to Treatments

The investigators aim to define the neurofunctional phenotype of migraine patients who did not respond to at least 3 preventive treatments, including monoclonal antibodies (mAbs)...

Sponsor: IRCCS National Neurological Institute "C. Mondino" FoundationEnrolling: 1001 location
RECRUITINGNCT06603558

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the...

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. The study will assess the...

Sponsor: AbbVieEnrolling: 30004 locations
RECRUITINGNCT06674772

Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification

Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to...

Sponsor: Hospital Universitari Vall d'Hebron Research InstituteEnrolling: 4401 location
RECRUITINGNCT06229834

Chiropractic Care for Episodic Migraine

Migraine, a chronic intermittent headache disorder, ranks in the top five causes of years lived with disability. One promising non-pharmacologic and integrative treatment for...

Sponsor: Brigham and Women's HospitalEnrolling: 601 location
RECRUITINGNCT04628429

CGRP Inhibition, Autonomic Function, and Migraine

The purpose of this clinical study is to better understand the function of the autonomic nervous system in patients with migraine. We aim to understand whether the autonomic...

Sponsor: Medical University of ViennaEnrolling: 1201 location
RECRUITINGPhase 3NCT05711394

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants...

A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light...

Sponsor: AbbVieEnrolling: 45020 locations
RECRUITINGPhase 2NCT06625060

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head. It is often accompanied by feeling or being sick and a sensitivity...

Sponsor: IpsenEnrolling: 64120 locations
RECRUITINGNCT07159750

Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine

The goal of this observational study is to evaluate clinical differences in patients who received preventive treatment with medication targeting calcitonin gene-related peptide...

Sponsor: Hospital Universitari Vall d'Hebron Research InstituteEnrolling: 70020 locations
RECRUITINGPhase 2NCT06248671

Prophylactic Treatment With Atorvastatin for Episodic Migraine.

The main objective of this study is to see whether the favorable preventative effect of Atorvastatin 40mg per day in episodic migraine, that was found previously in three smaller...

Sponsor: St. Olavs HospitalEnrolling: 4506 locations